KHEDEZLA Drug Patent Profile
✉ Email this page to a colleague
When do Khedezla patents expire, and when can generic versions of Khedezla launch?
Khedezla is a drug marketed by Osmotica Pharm Corp and is included in one NDA.
The generic ingredient in KHEDEZLA is desvenlafaxine. There are sixteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the desvenlafaxine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Khedezla
A generic version of KHEDEZLA was approved as desvenlafaxine by ALEMBIC PHARMS LTD on March 4th, 2013.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for KHEDEZLA?
- What are the global sales for KHEDEZLA?
- What is Average Wholesale Price for KHEDEZLA?
Summary for KHEDEZLA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 122 |
| Patent Applications: | 2,579 |
| Drug Prices: | Drug price information for KHEDEZLA |
| DailyMed Link: | KHEDEZLA at DailyMed |
US Patents and Regulatory Information for KHEDEZLA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Osmotica Pharm Corp | KHEDEZLA | desvenlafaxine | TABLET, EXTENDED RELEASE;ORAL | 204683-001 | Jul 10, 2013 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Osmotica Pharm Corp | KHEDEZLA | desvenlafaxine | TABLET, EXTENDED RELEASE;ORAL | 204683-002 | Jul 10, 2013 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
